CVS-Aetna Deal Nears Antitrust OK As Drug Plan Divestitures Loom

CVS Health executives appear confident the acquisition of Aetna will survive antitrust scrutiny though there may be divestitures where the two sell overlapping Medicare drug coverage.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive